Survey results suggest that cancer patients are willing to wait for the approval of drugs that are more likely to provide a survival benefit.

(HealthDay News) — For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a lower risk for venous thromboembolism (VTE), ...

Rates of suicide have increased for cancer patients of all ages, but the highest suicide death rate was observed in male adolescents and young adults.

Adults with chronic kidney disease (CKD) or type 2 diabetes develop cardiovascular diseases (CVD) at younger ages.

(HealthDay News) — Many young patients with early-onset cancer report having a fertility preservation (FP) discussion with their health care professional prior to treatment, according to a research ...

More than one third of patients receiving first-line chemotherapy for metastatic bladder cancer did not have guideline-recommended treatment adherence.

Doubling to tripling of odds seen when temperatures reach extreme heat levels. (HealthDay News) — There is a dose-response relationship between rising outdoor temperatures and increased atrial ...

Denosumab treatment for osteoporosis appears more hazardous in postmenopausal women with advanced chronic kidney disease (CKD).

(HealthDay News) — For patients with obesity and prediabetes, 3 years of tirzepatide yields substantial and sustained weight reduction and a reduced risk for progression to type 2 diabetes, according ...

Most common adverse events related to surgical procedures, adverse drug events, health care-associated infections ...

Calcium levels decreased less with each subsequent denosumab dose among individuals with osteoporosis and advanced chronic kidney disease.

A large study suggests that, across the most populous US states, few physicians are disciplined for spreading medical misinformation.